NCI vs PKE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

NCI

53.6
AI Score
VS
NCI Wins

PKE

37.2
AI Score

Investment Advisor Scores

NCI

54score
Recommendation
BUY

PKE

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI PKE Winner
Forward P/E 0 17.094 Tie
PEG Ratio 1.13 1.4854 NCI
Revenue Growth -50.8% 18.9% PKE
Earnings Growth 34.0% 69.2% PKE
Tradestie Score 53.6/100 37.2/100 NCI
Profit Margin 0.2% 16.7% PKE
Beta 1.00 1.00 Tie
AI Recommendation BUY SELL NCI

Relative Price Performance (Last 90 Days)

NCI 1M: +10.9% · 3M: +44.3% PKE 1M: -1.2% · 3M: +2.7%

Current Technical Phase

NCI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.4% over 20 days), RSI 69

RSI (14): 68.8 · Price: $12.99

PKE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.7 · Price: $33.88

Fundamentals Snapshot

Metric NCI PKE
Market Cap
Forward P/E 0.0 17.1
Trailing P/E 155.1 58.2
Revenue (TTM)
Revenue Growth -0.5% 0.2%
Gross Margin 0.4% 0.3%
Operating Margin 0.0% 0.2%
EPS 0.08 0.61
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, NCI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.